A detailed history of Franklin Resources Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Franklin Resources Inc holds 3,563,853 shares of BMY stock, worth $206 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
3,563,853
Previous 3,563,853 -0.0%
Holding current value
$206 Million
Previous $184 Million -0.0%
% of portfolio
0.06%
Previous 0.05%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$39.66 - $51.75 $87.8 Million - $115 Million
-2,213,071 Reduced 38.31%
3,563,853 $184 Million
Q2 2024

Aug 14, 2024

SELL
$40.25 - $52.99 $233 Million - $307 Million
-5,795,122 Reduced 50.08%
5,776,924 $240 Million
Q1 2024

May 13, 2024

BUY
$47.98 - $54.4 $106 Million - $120 Million
2,214,847 Added 23.67%
11,572,046 $628 Million
Q4 2023

Feb 09, 2024

BUY
$48.48 - $57.85 $122 Million - $145 Million
2,510,134 Added 36.66%
9,357,199 $480 Million
Q3 2023

Nov 13, 2023

BUY
$57.89 - $64.73 $88.3 Million - $98.7 Million
1,524,631 Added 28.65%
6,847,065 $397 Million
Q2 2023

Aug 11, 2023

BUY
$63.71 - $70.74 $100 Million - $111 Million
1,569,932 Added 41.84%
5,322,434 $340 Million
Q1 2023

May 12, 2023

BUY
$65.71 - $74.53 $65 Million - $73.7 Million
989,027 Added 35.79%
3,752,502 $260 Million
Q4 2022

Feb 10, 2023

SELL
$68.48 - $81.09 $408 Million - $483 Million
-5,957,437 Reduced 68.31%
2,763,475 $199 Million
Q3 2022

Nov 14, 2022

SELL
$0.13 - $76.84 $439,251 - $260 Million
-3,378,854 Reduced 27.92%
8,720,912 $620 Million
Q2 2022

Aug 11, 2022

SELL
$72.62 - $79.98 $278 Million - $306 Million
-3,822,933 Reduced 24.01%
12,099,766 $932 Million
Q1 2022

May 13, 2022

BUY
$61.48 - $73.72 $144 Million - $172 Million
2,338,579 Added 17.22%
15,922,699 $1.16 Billion
Q4 2021

Feb 11, 2022

SELL
$53.63 - $62.52 $20.2 Million - $23.5 Million
-376,253 Reduced 2.7%
13,584,120 $847 Million
Q3 2021

Nov 12, 2021

SELL
$59.17 - $69.31 $111 Million - $129 Million
-1,867,872 Reduced 11.8%
13,960,373 $826 Million
Q2 2021

Aug 13, 2021

SELL
$61.91 - $67.42 $225 Million - $245 Million
-3,640,181 Reduced 18.7%
15,828,245 $1.06 Billion
Q1 2021

May 13, 2021

BUY
$59.34 - $66.74 $307 Million - $345 Million
5,172,488 Added 36.18%
19,468,426 $1.23 Billion
Q4 2020

Feb 10, 2021

BUY
$57.74 - $65.43 $292 Million - $331 Million
5,062,692 Added 54.83%
14,295,938 $887 Million
Q3 2020

Nov 12, 2020

BUY
$57.43 - $63.64 $102 Million - $113 Million
1,772,127 Added 23.75%
9,233,246 $557 Million
Q2 2020

Aug 13, 2020

SELL
$54.82 - $64.09 $4.52 Million - $5.28 Million
-82,447 Reduced 1.09%
7,461,119 $447 Million
Q1 2020

May 13, 2020

SELL
$46.4 - $67.43 $111 Million - $161 Million
-2,382,366 Reduced 24.0%
7,543,566 $420 Million
Q4 2019

Feb 12, 2020

SELL
$49.21 - $64.19 $287 Million - $374 Million
-5,832,550 Reduced 37.01%
9,925,932 $637 Million
Q3 2019

Nov 14, 2019

BUY
$42.77 - $50.71 $17 Million - $20.2 Million
398,031 Added 2.59%
15,758,482 $799 Million
Q2 2019

Aug 14, 2019

BUY
$44.62 - $49.34 $424 Million - $469 Million
9,507,798 Added 162.45%
15,360,451 $697 Million
Q1 2019

May 14, 2019

BUY
$45.12 - $53.8 $207 Million - $247 Million
4,591,269 Added 363.99%
5,852,653 $279 Million
Q4 2018

Feb 12, 2019

BUY
$48.76 - $63.23 $27.2 Million - $35.3 Million
558,475 Added 79.45%
1,261,384 $65.6 Million
Q3 2018

Nov 13, 2018

SELL
$55.19 - $62.25 $179 Million - $202 Million
-3,239,216 Reduced 82.17%
702,909 $43.6 Million
Q2 2018

Aug 14, 2018

BUY
$50.53 - $62.98 $123 Million - $153 Million
2,425,602 Added 159.94%
3,942,125 $218 Million
Q1 2018

May 10, 2018

SELL
$59.92 - $68.98 $119 Million - $136 Million
-1,978,598 Reduced 56.61%
1,516,523 $95.9 Million
Q4 2017

Feb 14, 2018

SELL
$59.94 - $65.35 $163 Million - $178 Million
-2,721,850 Reduced 43.78%
3,495,121 $214 Million
Q3 2017

Nov 13, 2017

BUY
$55.23 - $63.74 $343 Million - $396 Million
6,216,971
6,216,971 $396 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.